CooperCompanies’ Q4 EPS Tops Estimates, Raises 2026 Guidance to $4.33B
CooperCompanies reported Q4 revenue of $1.02 billion, matching estimates, and delivered adjusted EPS of $1.10, a 6.9% beat over forecasts. Full-year revenue guidance midpoint was raised to $4.33 billion with EPS outlook of $4.62, citing efficiencies and MyDay/MiSight launches, while Japan hydrogel softness may weigh on Asia Pacific growth.
1. Q4 Financial Results
CooperCompanies delivered Q4 revenue of $1.02 billion, up 6.2% year-on-year and matching estimates, while adjusted EPS reached $1.10, a 6.9% beat. Adjusted EBITDA was $337.8 million for a 33% margin, lifting operating margin to 20.8% from 18.9% a year earlier.
2. Guidance and Outlook
The company raised full-year revenue guidance midpoint to $4.33 billion and adjusted EPS outlook to $4.62, citing efficiencies and technology-driven cost savings. Management expects continued margin expansion and free cash flow growth through disciplined capital allocation and share repurchases.
3. Regional and Product Drivers
Asia Pacific performance was held back by softness in legacy hydrogel products in Japan, offsetting gains from new MyDay and MiSight launches. MiSight grew 23% with recent rollouts in Europe and Japan, while management targets a regional recovery later this year as new products gain traction.